Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

British Journal of Cancer (5)
Modern Pathology (1)
Oncogene (1)
Nature (1)
Nature Genetics (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (9)

Subject Check one or more subjects to show results from those subjects only.

Biological techniques
Cancer
Diseases
Genetics
Health care
Medical research
Molecular biology
Molecular medicine
Oncology
Social sciences

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–9 of 9 results

Advanced filters: Author: Tamas Hickish Clear advanced filters

The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer

A study details the results of the PARTNER trial, a prospective, randomized controlled trial of the use of neoadjuvant olaparib with carboplatin–paclitaxel chemotherapy in patients with triple-negative breast cancer who were germline BRCA1 and BRCA2 wild type.

Jean E. Abraham
Karen Pinilla
Helena M. Earl
ResearchOpen Access08 Apr 2024
Nature

Volume: 629, P: 1142-1148
Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial

Edouard Auclin
Thierry André
Dewi Vernerey
ResearchOpen Access12 Jul 2019
British Journal of Cancer

Volume: 121, P: 312-317
Inhibition of in vitro proliferation of Epstein Barr Virus infected B cells by an antisense oligodeoxynucleotide targeted against EBV latent membrane protein LMP1

Elena Mattia
Silvia Chichiarelli
Jos van Renswoude
Research24 Jul 1997
Oncogene

Volume: 15, P: 489-493
SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer

José Robles-Zurita
Kathleen A. Boyd
James Paul
ResearchOpen Access13 Nov 2018
British Journal of Cancer

Volume: 119, P: 1332-1338
A UK prospective multicentre decision impact, decision conflict and economic evaluation of the 21-gene assay in women with node+ve, hormone receptor+ve, HER2-ve breast cancer

Simon Holt
Mark Verrill
Saira Khawaja
ResearchOpen Access02 Feb 2024
British Journal of Cancer

Volume: 130, P: 1149-1156
Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study

Siân A Pugh
Megan Bowers
John N Primrose
ResearchOpen Access19 Jul 2016
British Journal of Cancer

Volume: 115, P: 420-424
Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk

Richard Houlston and colleagues report a genome-wide association study for colorectal cancer. They report three loci newly associated with colorectal cancer, bringing the total number of common susceptibility loci to 20.

Malcolm G Dunlop
Sara E Dobbins
Richard S Houlston
Research27 May 2012
Nature Genetics

Volume: 44, P: 770-776
Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial

Jeremy St John Thomas
Elena Provenzano
Helena Margaret Earl
Research26 May 2017
Modern Pathology

Volume: 30, P: 1069-1077
Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array

Edward J Saunders
Tokhir Dadaev
Zsofia Kote-Jarai
ResearchOpen Access10 Mar 2016
British Journal of Cancer

Volume: 114, P: 945-952